Clinical trial
Detection of Myocardial Metabolic Changes in Patients With Cardiomyopathy Using Hyperpolarized Carbon 13 Magnetic Resonance Spectroscopic Imaging
NCT03057002 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of Myocardial Metabolic Changes in Patients With Cardiomyopathy Using Hyperpolarized Carbon 13 Magnetic Resonance Spectroscopic Imaging
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2018
- Completion date
- May 17, 2023
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
becker muscular dystrophy, cardiac sarcoidosis, cardiomyopathy, hypertrophic, dilated cardiomyopathy, duchenne muscular dystrophy, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction